Regeneron Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -3.06%72.471.0%$1887.03m
AMGNAmgen, Inc. -2.41%197.841.3%$881.55m
REGNRegeneron Pharmaceuticals, Inc. 1.89%497.542.6%$849.60m
BIIBBiogen, Inc. -7.23%293.511.5%$704.33m
VRTXVertex Pharmaceuticals, Inc. -5.29%225.361.9%$557.17m
MRNAModerna, Inc. -0.74%29.730.0%$531.71m
ILMNIllumina, Inc. -6.16%256.303.5%$443.16m
ALXNAlexion Pharmaceuticals, Inc. 0.15%89.922.0%$286.46m
AAgilent Technologies, Inc. -3.90%68.831.6%$219.69m
EXASEXACT Sciences Corp. -3.81%55.7921.0%$186.98m
INCYIncyte Corp. 1.24%74.142.5%$178.78m
BMRNBioMarin Pharmaceutical, Inc. -1.15%83.534.3%$164.46m
SGENSeattle Genetics, Inc. -3.57%111.276.1%$163.46m
NVAXNovavax, Inc. 3.17%14.01114.7%$128.78m
ALNYAlnylam Pharmaceuticals, Inc. -3.77%104.758.7%$98.57m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.